What researchers published on Chronic lymphocytic leukaemia
947 papers, newest first.
Showing 200 of 947
Late-Onset Invasive Aspergillosis Following Acalabrutinib in 2 Patients With Chronic Lymphocytic Leukemia: A Case Report.Open forum infectious diseases
Case reportExtensive Native Aortic Valve Infiltration and Early Bioprosthetic Valve Degeneration in Low-Grade Chronic Lymphocytic Leukemia.JACC. Case reports
Fit for the fight: BTK inhibitors prime CAR T cells in CLL.Blood
Rapid identification of the high-risk IGLV3-21R110 subgroup of chronic lymphocytic leukemia by flow cytometry.Haematologica
Paraneoplastic spongiotic dermatitis associated with progression to treatment-requiring chronic lymphocytic leukemia.Haematologica
Intercellular transfer of FOLR2 from nurse-like cells fuels chronic lymphocytic leukemia cell activation and proliferation.Haematologica
Glucagon-like peptide-1 receptor agonist exposure is associated with lower secondary malignancy risk during watch-and-wait in chronic lymphocytic leukemia: a timevarying analysis.Haematologica
Efficacy of continuous zanubrutinib monotherapy versus fixed-duration acalabrutinib plus venetoclax or venetoclax plus obinutuzumab in treatment-naïve chronic lymphocytic leukemia: a network meta-analysis.Leukemia & lymphoma
How Many Lines of Therapy Do Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Receive in Routine Clinical Practice in the United States? Real World Evidence From the Targeted Therapy Era.Clinical lymphoma, myeloma & leukemia
Social vulnerability index associates with chronic lymphocytic leukemia survival rates in the Detroit tri-county area.Cancer research communications
Borderline tuberculoid leprosy with type 1 reaction mimicking leukaemia cutis in a patient with chronic lymphocytic leukaemia on acalabrutinib.BMJ case reports
Optimizing CLL treatment after covalent BTK inhibition.Clinical advances in hematology & oncology : H&O
Case reportZanubrutinib Combined With Venetoclax for the Treatment of Central Nervous System-Involved Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Rare Case Report.Cancer reports (Hoboken, N.J.)
Terminal differentiation program of CD8 T cells guides immunotherapeutic options for CLL patients.Blood
ADGRE2: A Promising Immunotherapeutic Target in Acute Myeloid Leukemia and Chronic Myelomonocytic Leukemia.Cancer medicine
Effects of Dioscin on NLRP3 Inflammasome Expression and Apoptosis in Chronic Lymphocytic Leukemia Cells.Immunopharmacology and immunotoxicology
Outcomes of Patients With Chronic Lymphocytic Leukemia Treated With Bruton Tyrosine Kinase Inhibitors (BTKi): A Retrospective Study From a Tertiary Healthcare Center in North India.Cureus
Real-world outcomes after second-line therapy in chronic lymphocytic leukemia: A population-based study.Leukemia research
Real-World Treatment Patterns, Tolerability, and Outcomes Among Patients With CLL/SLL Treated With First-Line Ibrutinib, Acalabrutinib, or Zanubrutinib in the US Community Oncology Setting: A Retrospective Cohort Study.EJHaem
Decision-Making on First-Line Treatment Alternatives in Chronic Lymphocytic Leukemia: A Multi-Criteria Decision Analysis to Elicit Stakeholders' Preferences in Italy.Hematological oncology
The evolving evidence ecosystem in chronic lymphocytic leukemia: from linear hierarchies to integrated synthesis.Expert review of hematology
A thyroid nodule consistent with chronic lymphocytic leukemia.Endocrinology, diabetes & metabolism case reports
Aptamers in cancer research: Focus on leukemia.Chinese medical journal
Beyond age: The prognostic impact of frailty on in-hospital outcomes in chronic lymphocytic leukemia.Journal of geriatric oncology
Exanthematous drug eruption with reactive T-cell atypia in a patient with accelerated chronic lymphocytic leukemia.International journal of women's dermatology
Quantitative systems pharmacology modeling identifies synthetic lethality opportunities with DNA damage response inhibitors in ATM-deficient chronic lymphocytic leukemia - a computational simulation study.Journal of pharmacokinetics and pharmacodynamics
ReviewChronic lymphocytic leukemia: recent advances and emerging therapeutic strategies.Blood research
Personalized Prediction of Venetoclax-Associated Tumor Lysis Syndrome in Acute Myeloid Leukemia Using Drug Exposure, Genetic Polymorphisms, and Clinical-Laboratory Characteristics.Drug design, development and therapy
Shortened Obinutuzumab Infusion Is Safe and Reduces Chair Time in Frontline Treatment of Chronic Lymphocytic Leukemia: A Real-World Study.Cancer medicine
Comment on "Costs and consequences of cardiovascular toxicity due to Bruton's tyrosine kinase inhibitors in chronic lymphocytic leukemia".Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology
Case reportConcurrent treatment of chronic lymphocytic leukemia and acquired von Willebrand syndrome using a Bruton tyrosine kinase inhibitor: a case report.Blood transfusion = Trasfusione del sangue
Case reportLeukemia Cutis at the Diagnosis of Chronic Lymphocytic Leukemia: A Case Report.Cureus
Scalable Arrayed T-cell CRISPR Screening in Autologous Tumor Co-cultures to Prioritize Combination Partners for T-cell Engagers.Current protocols
Real-World Treatment Patterns and Outcomes of Zanubrutinib and Acalabrutinib in Patients with Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma at University of California Academic Health Centers: A Retrospective Cohort Study.Oncology and therapy
Measurable residual disease is not a universally reliable surrogate for progression-free survival in clinical trials of new chronic lymphocytic leukemia therapies.Leukemia
T cell-driven venetoclax resistance in chronic lymphocytic leukemia: in vivo preclinical activity of opaganib.Frontiers in immunology
Case reportCD23-negative atypical chronic lymphocytic leukemia with a novel three-way translocation t(4;10;13), unmutated: immunoglobulin heavy chain variable gene, and stereotyped subset #6 (case report).The Pan African medical journal
TAILORing ibrutinib dose and plasma levels in the real-life patient with chronic lymphocytic leukemia.The Journal of pharmacology and experimental therapeutics
Correlation of Epstein-Barr virus (EBV) expressed miRNAs (BART4, BART7, and BHRF1) with chronic lymphocytic leukemia stages.Infectious agents and cancer
ReviewNavigating Measurable Residual Disease as a Surrogate Endpoint in Chronic Lymphocytic Leukemia.Hematological oncology
ReviewRichter Transformation of Chronic Lymphocytic Leukaemia: Biology, Diagnosis, and an Evolving Therapeutic Landscape.Biomedicines
Real-world effectiveness and safety of fixed-duration frontline venetoclax-obinutuzumab for chronic lymphocytic leukemia: A nationwide multicenter retrospective cohort study.Leukemia research
Association of Cbl-Interacting Protein CIN85 with Protein Phosphatase 2A (PP2A) Partly Confer Neoplastic Properties to Human Leukemia Cell Lines.Cells
Expression of TCTP/HRF and MCL-1 in chronic lymphocytic leukemia: implications for disease pathogenesis.Molecular biology reports
The genomic and transcriptomic landscape of chronic lymphocytic leukaemia: Insights from an integrated analysis of 275 patients.British journal of haematology
PTPN2/PTPN1 inhibition enhances ex vivo T- cell responses and potentiates mosunetuzumab activity in chronic lymphocytic leukemia.Frontiers in immunology
Case reportCollision of Malignant Melanoma and Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia: A Case Report and Literature Review.Dermatopathology (Basel, Switzerland)
Targeting PRMT5 with indole-based arylsulfonylhydrazides: a novel epigenetic strategy for the treatment of acute and chronic leukemia.American journal of cancer research
Pulmonary Involvement in Chronic Lymphocytic Leukemia: A Structured Diagnostic Approach to Diffuse Infiltrates-A Case Report.EJHaem
Concordance between bone marrow and blood measurable residual disease after first-line novel agent treatment for chronic lymphocytic leukemia: a systematic review and meta-analysis.Leukemia
USP7 inhibits FOXO1 activity in chronic lymphocytic leukaemia cells enhancing cell survival.Molecular oncology
IκBζ target genes in chronic lymphocytic leukemia.iScience
Pirtobrutinib for the Treatment of Therapy-Resistant Chronic Lymphatic Leukemia With CNS Localization.Case reports in hematology
Case reportProlonged Active SARS-CoV-2 Infection in a Patient With Chronic Lymphocytic Leukemia on Venetoclax.Cureus
TP53 mutations and IGHV in naïve chronic lymphocytic leukemia: retrospective analysis of data from a Spanish collaborative network.International journal of hematology
Immunoglobulin kinetics and infection patterns across venetoclax-based regimens in chronic lymphocytic leukemia.Leukemia & lymphoma
Survival Outcomes in Chronic Lymphocytic Leukemia During the Novel Agent Era: A Population-Based Analysis.Cancer medicine
A Novel BCL2 Translocation and Concurrent Chromosome 13q14 Deletion in Chronic Lymphocytic Leukemia: A Case Report.EJHaem
MRD-guided ibrutinib plus venetoclax improves quality of life in relapsed/refractory CLL: HOVON 141/VISION trial results.Blood advances
Case reportAn Atypical Presentation of Richter's Transformation in Chronic Lymphocytic Leukemia: Stroke-Like Onset With Multiorgan Involvement Including the Heart and Seminal Vesicles.Cureus
Correction: Clinical and transcriptomic characterization of patients with chronic lymphocytic leukemia harboring t(14;19): an ERIC study.Leukemia
Clinical characteristics and outcome of a cohort of CLL patients with BTK T474 gatekeeper mutation.Blood advances
Observational studyEfficacy of continuous ibrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia with high-burden and low-burden TP53 mutations: Multicenter retrospective analysis of the Polish Adult Leukemia Group (PALG).Advances in clinical and experimental medicine : official organ Wroclaw Medical University
ReviewStereotyped CLL-like immunoglobulin rearrangements in healthy repertoires: implications for leukemogenesis.Frontiers in immunology
Treatment adherence in chronic lymphocytic leukaemia and chronic myeloid leukaemia: An integrative review.Enfermeria clinica
Cord blood-derived natural killer cells engineered with a novel, highaffinity chimeric antigen receptor can eliminate acute myeloid leukemia cells with minimal C-type lectin-like molecule-1 expression.Haematologica
The maturation of precision medicine into pragmatic, patient-centered care: A commentary on the 2026 EHA CLL Guidelines.HemaSphere
Comment on "EHA Guidelines on management of chronic lymphocytic leukemia and Richter transformation".HemaSphere
From Daffodils to Drug Leads: Amaryllidaceae Alkaloids Target Protein Translation in Chronic Lymphocytic Leukemia to Induce Selective Apoptosis.ACS pharmacology & translational science
Defects in ribosomes and translational control in lymphoid leukemia and lymphoma.Seminars in hematology
A Rare Case of Chronic Lymphocytic Leukemia and Chronic Myeloid Leukemia in an Elderly Patient: A Case Report.Clinical case reports
Case reportDiagnosis of acute myeloid leukaemia in a previously diagnosed case of chronic lymphocytic leukaemia in a dog.Australian veterinary journal
Case reportFalse-negative HHV-8 immunohistochemistry in Kaposi sarcoma: Clinicopathologic correlation leading to diagnosis of occult chronic lymphocytic leukemia.JAAD case reports
Aplastic Anaemia in a Chronic Lymphocytic Leukaemia Patient Treated With Acalabrutinib, a Bruton Tyrosine Kinase Inhibitor-Case Report.EJHaem
Influence of gut microbiota on chronic lymphocytic leukemia development and aggressiveness.Gut microbes reports
[Chronic lymphocytic leukemia presenting initially as purpura nephritis: a case report].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
ReviewBruton Tyrosine Kinase Inhibitor-Based Therapy Versus Rituximab-Containing Regimens for Chronic Lymphocytic Leukemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Cureus
Response to two comments on "EHA Guidelines on management of chronic lymphocytic leukemia and Richter transformation" by S. Molica and A. Tedeschi: Beyond the binary choice.HemaSphere
Immunomodulatory Receptor ILT3/LILRB4 Protects Human Leukemic B Cells From Ferroptosis In Vitro.European journal of immunology
Real-world treatment patterns and outcomes in patients with chronic lymphocytic leukemia previously exposed to both covalent Bruton's tyrosine kinase inhibitor and B-cell lymphoma 2 inhibitor therapy.Haematologica
Persistent SARS-CoV-2 RNA Positivity in a Chronic Lymphocytic Leukaemia Patient for 127 Days After Disease Onset: A Case Report.Respirology case reports
Telomere length in chronic lymphocytic leukemia treated with venetoclax-based regimen in GAIA/CLL13 and CLL2-GIVe trials.Blood
Single-cell sequencing reveals transcriptional and immunogenetic diversity in stereotyped chronic lymphocytic leukemia.Blood neoplasia
EVIDENCE OF CLL DEVELOPMENT FROM HEMATOPOIETIC PROGENITOR CELLS IN HUMANS.Blood
TLR9-dependent migration identifies different Chronic Lymphocytic Leukemia signaling states under BTK inhibition.Blood
Diagnosis and Management of Chronic Lymphocytic Leukemia with TP53 Loss of Function in the Novel Agent Era.Blood
Extranodal Organ Involvement in Chronic Lymphocytic Leukemia: Clinical Features and Outcomes With Bruton Tyrosine Kinase and BCL-2 Inhibitors.Cancer medicine
Case reportChronic lymphocytic leukemia associated with genetic susceptibility and occupational glyphosate exposure: a case report.Frontiers in oncology
First-line ibrutinib-venetoclax in chronic lymphocytic leukemia: GLOW 67-month results and grade 3/4 adverse event-free progression-free survival.Leukemia
ZNF292 mutations impair RNA and protein biosynthesis defining an adverse prognostic subset in early-stage chronic lymphocytic leukemia.Biomarker research
Plasmablastic Richter Transformation of Chronic Lymphocytic Leukemia With Aberrant Epithelial Marker Expression Presenting as a Pleural Effusion: A Diagnostic Challenge.Case reports in pathology
Inhibition of ROR1 signaling with zilovertamab plus ibrutinib in chronic lymphocytic leukemia: safety, mechanistic insights, and an exploratory signal in del(17p) disease.Leukemia
Case reportFirst reported human Castellaniella defragrans bacteraemia: a case report.Swiss medical weekly
Refractory Chronic Lymphocytic Leukemia Successfully Bridged to CAR T-Cell Therapy Using Splenic Radioembolization.Journal of vascular and interventional radiology : JVIR
Venetoclax consolidation deepens response and enables measurable residual disease-guided finite therapy in BTK inhibitor-treated chronic lymphocytic leukemia.Leukemia & lymphoma
Case reportClinical improvement of pemphigus-like mucocutaneous disease in a patient with CLL following initiation of zanubrutinib: a case report.Frontiers in immunology
Clinical Flow Cytometric Testing in Chronic Lymphocytic Leukemia.Methods in molecular biology (Clifton, N.J.)
ReviewTargeting the Epigenetic-Immune Axis in Acute Myeloid Leukemia: Current Advances and Future Directions.Current oncology reports
Renal risk differences between diffuse large B-cell lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: implications for supportive oncology care.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ReviewCurrent management of central nervous system involvement in chronic lymphocytic leukemia/small lymphocytic lymphoma.International journal of hematology
ReviewZAP-70 as a prognostic laboratory biomarker in chronic lymphocytic leukemia: flow-cytometric assessment, clinical utility, and standardization challenges.Clinica chimica acta; international journal of clinical chemistry
ReviewLymph node models of chronic lymphocytic leukemia for translational evaluation of new drug candidates.Expert opinion on drug discovery
TLR8 Stimulation Leads to Microenvironment Activation and Enhanced Antibody-Dependent Cellular Responses in CLL.International journal of molecular sciences
Gene expression analysis after BTK and PI3Kδ inhibitor treatment in chronic lymphocytic leukemia identifies cell-surface CXCR4 as a synergistic target for combinatorial therapy.HemaSphere
Circulating Extracellular Vesicle Biomarkers in Chronic Lymphocytic Leukemia: A Preliminary Study on Their Diagnostic, Prognostic, and Predictive Relevance.Biomolecules
Hodgkin lymphoma transformation in patients with chemotherapy-naïve chronic lymphocytic leukemia.Blood cancer journal
A prospective, multi-center, phase IV clinical study to assess the safety and clinical outcome of acalabrutinib in Indian adult patients with chronic lymphocytic leukemia/small lymphocytic lymphoma or relapsed/refractory mantle cell lymphoma.Frontiers in oncology
Transcriptomic and miRNA-Target Pathway Analysis of the DLK1-DIO3 Imprinted microRNA Cluster in Chronic Lymphocytic Leukemia.Diseases (Basel, Switzerland)
In-frame variants in TP53 gene identified in adult leukemia samples are predominantly deleterious: a study of the TP53 Network of Education and Research Initiative on CLL.The Journal of pathology
Aberrant expression of MERTK activates BCR via CD79a in CLL cells: alternative therapeutic strategy for relapsed/refractory CLL.Leukemia
ReviewNon-Malignant T Cells as Determinants of Immunotherapeutic Response in Chronic Lymphocytic Leukemia: Towards Personalized Strategies.Oncology research
Early-onset CLL is characterized by enhanced microenvironment-driven metabolic fitness, increased proliferative bias, and accelerated disease progression.Frontiers in immunology
Prospective patient preference study for chronic lymphocytic leukemia (CLL) treatment attributes impacting patient shared decision-making.Expert review of anticancer therapy
Lenalidomide maintenance after initial immunochemotherapy in chronic lymphocytic leukaemia-Final analysis of the international phase III CLL6 RESIDUUM study of the ALLG and FILO groups.British journal of haematology
Case reportEmergence of Two Rare Malignancies, Langerhans Cell Sarcoma and Myeloid Sarcoma, After Targeted Therapy for Chronic Lymphocytic Leukaemia: A Case Report.Cureus
Acquired Amegakaryocytic Thrombocytopenia Presenting as Pancytopenia in a Patient With Chronic Lymphocytic Leukemia: A Case Report.Case reports in hematology
Case reportAcute myeloid leukemia arising in treated chronic lymphocytic leukemia/small lymphocytic lymphoma: a challenge in analysis of lineage relationship.Journal of hematopathology
Infiltrative Nephropathy in Chronic Lymphocytic Leukaemia/Small Lymphocytic Lymphoma: A Systematic Review and Attribution Analysis.Journal of nephrology
Case reportExtragenital Mycoplasma hominis infection following obinutuzumab therapy in a patient with chronic lymphocytic leukemia.IDCases
ReviewProgress in reprogramming failed graft-versus-leukemia immunity in acute myeloid leukemia relapse after allogeneic transplantation.Frontiers in immunology
A functional prognostic model predicts progression-free survival in patients with relapsed chronic lymphocytic leukemia treated with ibrutinib + venetoclax.HemaSphere
Autoimmune hemolytic anemia and chronic lymphocytic leukemia: crossing the borders between autoimmunity and malignancy.Haematologica
ReviewGlobal incidence of chronic lymphocytic leukemia: A systematic review and meta-analysis.Cancer epidemiology
Real-World Determinants of Treatment Selection in Frontline Chronic Lymphocytic Leukemia: The FIRST-CLL Study.Hematological oncology
Case reportFrom breath to block: Disseminated invasive aspergillosis presenting with pulmonary, ocular, myocardial and cerebral involvement, and high-grade atrioventricular block during acalabrutinib therapy for chronic lymphocytic leukaemia.IDCases
Case reportOptic nerve infiltration in chronic lymphocytic leukemia treated with acalabrutinib monotherapy: A case report.American journal of ophthalmology case reports
High-dimensional spectral flow cytometry uncovers progressive T-cell exhaustion and myeloid cell reprogramming in a CLL mouse model.HemaSphere
Timing matters: Impact of covalent BTK inhibitor dose modifications on outcomes in chronic lymphocytic leukemia/small lymphocytic leukemia-A 7-year real-world study.Cancer
Fixed-treatment duration venetoclax following covalent BTKi progression in chronic lymphocytic leukemia.Blood neoplasia
A Case of Pseudo-Richter Transformation Following Zanubrutinib Discontinuation in CLL.Mediterranean journal of hematology and infectious diseases
Association between patient-reported symptoms and clinical outcomes in R/R CLL.Blood advances
The place of acalabrutinib-obinutuzumab combination in the first-line treatment of patients with chronic lymphocytic leukemia.Translational cancer research
Correction to "Studying Chronic Lymphocytic Leukemia Microenvironment in the Multi Omics Era".Hematological oncology
Case reportAppearances can be deceptive: acute myeloid leukaemia simulating chronic lymphocytic leukaemia.Advances in laboratory medicine
ReviewTherapeutic ecology of the fiber-microbiota-barrier axis in leukemia: resilience, immune recovery and pharmacomicrobiomics.Frontiers in microbiology
Utility of WBC Scatterplots and Suspect Flags Generated by Beckman Coulter LH-750 Hematology Analyzer in the Characterization of Leukemias and Related Hematological Malignancies.Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion
Case reportSuccessful distal splenic artery embolization in a patient with chronic lymphocytic leukemia complicated by thrombocytopenia and splenic artery aneurysm.Radiology case reports
Epidemiology, Presenting Features and Treatment Outcomes of Patients With Chronic Lymphocytic Leukemia (CLL) in Tanzania.Hematological oncology
Predicted microbiome-associated metabolic pathways are linked to immune checkpoint modulation in chronic lymphocytic leukaemia.British journal of haematology
Clonally Related Chronic Lymphocytic Leukemia and Malignant Histiocytic Neoplasm (Histiocytic Sarcoma With Overlapping Langerhans Cell Phenotype): Divergent Evolution From a Shared Cell-Of-Origin.American journal of hematology
Unveiling the anticancer potential of genus Aerva as therapeutics for CLL (Chronic Lymphocytic Leukemia): from plant to patient.Folia microbiologica
Observational studyAn Observational Study of Patients With Chronic Lymphocytic Leukemia Treated With Fixed Duration Therapy in a 1L Setting in Canada.Clinical lymphoma, myeloma & leukemia
RNA sequencing detects more challenging cases of somatic hypermutation in the IgHV gene in patients with chronic lymphocytic leukemia.Turkish journal of medical sciences
Bioinformatic analysis and characterization of the anti-CD20 scFv-conjugated Fe3O4 nanoparticles for targeted therapy of CD20+ leukemia cells.Iranian journal of basic medical sciences
Sequencing asymmetry: the case for caution before first-line pirtobrutinib in chronic lymphocytic leukemia.Annals of hematology
Ibrutinib versus allogeneic haematopoietic stem cell transplant in relapsed/refractory del(17p) chronic lymphocytic leukaemia/small lymphocytic lymphoma.British journal of haematology
Prognostic value of patient-reported outcome thresholds on survival and adverse events in CLL/SLL: A pooled analysis of ibrutinib trials.Therapeutic advances in hematology
Corrigendum to "Disappearance of the Defining Organized Ultrastructural Lesion in Chronic Lymphocytic Leukemia-Associated Monoclonal Immunotactoid Glomerulopathy After Ibrutinib Therapy" [Kidney International Reports Volume 11, Issue 8, August 2026, 106643].Kidney international reports
Case reportCase Report and Retrospective Review of Acanthamoeba Encephalitis and Chronic Lymphocytic Leukemia, United States.Emerging infectious diseases
Case reportDual Loss of Surface CD3 and CD45 in a TCL1-Negative T-Prolymphocytic Leukemia With Concurrent CLL/SLL.International journal of laboratory hematology
Refined Continuous Risk Index for Accurately Predicting Outcomes of Patients With Chronic Lymphocytic Leukemia After Limited-Duration Therapy.Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Meta-analysisCardiac Adverse Events in Patients With Chronic Lymphocytic Leukemia Treated With First-Line Ibrutinib-Venetoclax.European journal of haematology
In plain wordsRead moreRead the paper on PubMedGenetic control of local mutation rates.Proceedings of the National Academy of Sciences of the United States of America
Optimal Chemotherapy Scheduling for Chronic Lymphocytic Leukemia Under Immune and Allergy Constraints.Entropy (Basel, Switzerland)
Longitudinal single-cell analysis reveals dynamic clonal competition and convergent evolution shaped by therapy sequencing in a young patient with chronic lymphocytic leukemia.Haematologica
ReviewRedefining Fitness in Chronic Lymphocytic Leukaemia: A Treatment-Specific Framework for the Targeted Therapy Era.Oncology
Case reportProgressive multifocal leukoencephalopathy in an untreated chronic lymphocytic leukemia patient: Case report and review of the literature.Radiology case reports
Drug Safety and Polypharmacy Signals in Ibrutinib-Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Age- and Sex-Specific FAERS Analysis of CYP3A Modifier and Antithrombotic Co-Exposure.Journal of clinical medicine
Early intervention in CLL: not a Chekhov's gun.Blood
Pirtobrutinib Monotherapy for First-Line Chronic Lymphocytic Leukemia: A Non-Anchored Indirect Comparison Using Reconstructed Patient-Level Data.Hematology reports
Correction: Have Fixed-Duration (FD) Regimens Delivered on Their Promise in Chronic Lymphocytic Leukemia and What Is the Future of FD Regimens? A Narrative Review.Advances in therapy
T-cell immunosenescence limits CD19 CAR T-cell function in chronic lymphocytic leukemia.Blood
ReviewConsensus-based ranking of determinants for frontline therapy selection in chronic lymphocytic leukemia: A conjoint analysis.Critical reviews in oncology/hematology
Concordant Shared Transcriptomic Signatures and Candidate Regulatory Features in Chronic Lymphocytic Leukemia and Multiple Myeloma.Oncology research
Prolymphocytic Progression in Chronic Lymphocytic Leukemia Without Richter Transformation: An Eighteen-Year Clinical-Diagnostic Correlation.Case reports in hematology
Orelabrutinib, fludarabine, cyclophosphamide, and obinutuzumab (OFCG) for first-line treatment of chronic lymphocytic leukemia: a multicenter phase II trial (cwCLL-001 trial).Journal of the National Cancer Center
Case reportRare Presentation of Sequential Mucosa-Associated Lymphoid Tissue Lymphoma, Follicular Lymphoma, and Chronic Lymphocytic Leukemia: A Case-Based Review.Journal of community hospital internal medicine perspectives
Case reportCase Report: Rapid Improvement of Chronic Lymphocytic Leukemia Infiltration of the Scalp by BCL2-Inhibitor.Case reports in oncology
Zanubrutinib versus fludarabine, cyclophosphamide and rituximab in fit, treatment-naïve patients with chronic lymphocytic leukemia: a matching-adjusted indirect comparison.Journal of comparative effectiveness research
Expression OF Concern: Increased Autocrine Interleukin-6 Production Is Significantly Associated With Worse Clinical Outcome in Patients With Chronic Lymphocytic Leukemia.Journal of cellular physiology
PreprintIndividualised but Specific Exercise Training Improves Physiologic Reserve and Reduces Frailty in Older Adults with Chronic Lymphocytic Leukaemia: A 12-Week Pragmatic Randomised Controlled Trial.medRxiv : the preprint server for health sciences
ReviewNovel targeted therapies for central nervous system involvement in chronic lymphocytic leukemia: A systematic review.Therapeutic advances in hematology
Case reportBilateral optic neuropathy secondary to chronic lymphocytic leukaemia infiltration.BMJ case reports
Mapping the Global Clinical Trial Landscape of Chimeric Antigen Receptor T-Cell Therapy for Chronic Lymphocytic Leukemia: Current Status and Future Perspectives.American journal of therapeutics
Minimal residual disease-guided ibrutinib and venetoclax in patients with chronic lymphocytic leukaemia and complex karyotype.British journal of haematology
Pulmonary Light Chain Deposition Disease in a Patient With Chronic Lymphocytic Leukemia.International journal of surgical pathology
Zanubrutinib, a New Bullet Against Chronic Lymphocytic Leukemia Even When Localized in Central Nervous System.Case reports in hematology
Case reportCentral nervous system involvement of chronic lymphocytic leukaemia with brain and spinal cord infiltration.BMJ case reports
Trends and socio-economic disparities in chronic lymphocytic leukaemia 2014-2022: An England-wide cohort study from the UNCOVER group.British journal of haematology
Observational studyVenetoclax in Combination With Chemo-Immunotherapy in Richter Transformation: A Real-Life Experience.Hematological oncology
TRAF1 S146 is constitutively phosphorylated in OP9-cultured primary chronic lymphocytic leukemia cells by PKN1/2.ImmunoHorizons
Cytogenetic Characteristics of Chronic Lymphocytic Leukemia Patients: A Single-Center Study From Morocco.Cureus
Case reportSkin Lesions Mimicking Mosquito Bites as the Initial Presentation of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.Cureus
Erratum: Brem EA, Shieh K, Juarez D, et al. A phase 1 study adding pitavastatin to venetoclax therapy in AML and CLL/SLL: a mechanism-based drug repurposing strategy. Blood Neoplasia. 2024;1(4):100036.Blood neoplasia
Evaluating genetic diversity differences within a likelihood framework.PloS one
Observational studyLong-Term Clinical Outcomes, Adherence, Persistence, and Adverse Event Management in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib.European journal of haematology
Case reportPapillary thyroid carcinoma in a patient with long-standing chronic lymphocytic leukemia: A case report.Oncology letters
Treatment, Monitoring, and Management of Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma: Evidence From a Multi-Country Needs Assessment.Cancer reports (Hoboken, N.J.)
Postoperative Complications Following Total Knee Arthroplasty in Patients with Chronic Lymphocytic Leukemia.Journal of clinical medicine
Pirtobrutinib in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Systematic Review.American journal of clinical oncology
Increased Frequency of the Chemokine Receptor CCR2 on Circulating CD19+CD5+ Lymphocytes in Therapy-Naïve CLL Patients With the Detectable EBV DNA and High-Avidity Antibodies Against the EBV Capsid Antigen.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale
ReviewTargeting Bruton's Tyrosine Kinase in CLL: Selectivity, Resistance Mechanisms, and Emerging Therapeutic Strategies.Cells
Lack of Consensus on Recurrence Timelines and Management of Cutaneous Squamous Cell Carcinoma in Chronic Lymphocytic Leukemia: A Systematic Review.Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
Economic Burden of Chronic Lymphocytic Leukaemia in Australia.European journal of haematology
Efficacy and tolerability of venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukemia - real-world analysis of Polish adult leukemia study group.Leukemia & lymphoma
Allogeneic Stem Cell Transplantation-A Salvage Option for High-Risk Chronic Lymphocytic Leukemia Patients: A 15-Year Single-Center Experience.Hematological oncology
BTK inhibitors are associated with a lower risk of myeloid neoplasms and non-melanoma skin cancer compared with chemoimmunotherapy in chronic lymphocytic leukemia: a propensity score-matched analysis.Leukemia
Real-World Outcomes of Venetoclax-Based Therapy in Treatment-Naïve and Relapsed/Refractory CLL/SLL: Interim Results From the Prospective REVEAL Study.American journal of hematology
Prognostic significance of baseline liver enzyme patterns in chronic lymphocytic leukemia: a nationwide real-world cohort study.Leukemia & lymphoma
The Unusual Coexistence of Chronic Lymphocytic Leukemia, Dengue Fever, and Acute Kidney Injury: A Case Report.Clinical case reports